PRESS RELEASE No 44/03
22 May 2003
Opinion of Advocate General Francis Jacobs in Joined Cases C-264/01, C-306/01, C-354/01 and
C-355/01
AOK Bundesverband and Others v Ichthyol-Gesellschaft Cordes and Others
THE ADVOCATE GENERAL CONSIDERS THAT THE FIXING OF AMOUNTS PAID FOR CERTAIN MEDICINES
BY GERMAN SICKNESS FUNDS IS, IN PRINCIPLE, CONTRARY TO COMPETITION LAW, BUT IS
CAPABLE OF JUSTIFICATION.
It is for the national courts to determine whether the sickness funds have
exercised any margin of discretion left open to them by national law in
an anti-competitive manner and whether the setting of fixed amounts is a manifestly
disproportionate method for ensuring the provision of a service of general economic interest.
Under German law, the great majority of employees are required to belong to
a statutory health insurance system unless their income exceeds a certain level. The
system is funded by compulsory contributions from the insured persons and their employers.
Ordinarily, the insurance funds are required to purchase medical services and supplies and
supply them to their insured persons. However, for certain products a maximum fixed
price is set and where the cost of the product exceeds that fixed
price, the insured person must bear the remainder of the cost. Only about
7% of medicinal products to which a fixed amount applies are priced at
a level above that amount.
The fixed amounts are decided in a two stage process. Firstly, a committee,
composed of representatives of the leading sickness fund associations and associations of doctors,
decide which types of products are to be subject to a fixed amount.
These selections are approved by the Ministry of Health. Secondly, the associations of
sickness funds together determine the fixed amounts following certain criteria laid down by
law. Once set, the fixed amounts are subject to annual review and must
be adapted to reflect changes in the market. They are also required to
be published and are open to challenge before the Courts.
A number of pharmaceutical companies (the respondents) challenged decisions of the leading associations
of sickness funds in Germany (the appellants) to alter the fixed amount payable
for their products. The respondents argued that the decision to fix prices was
anti-competitive behaviour, prohibited by Community competition law. The German courts hearing the appeals
referred questions to the Court of Justice of the EC as to whether
Community competition law was applicable to these associations of sickness funds, whether the
decisions to set fixed amounts was contrary to Community law and whether those
decisions could be justified as being necessary for the provision of a service
of general economic interest.
Advocate General Jacobs delivers his Opinion in this case today.
The view of the Advocate General is not binding on the Court of Justice. The task of an Advocate General is to propose to the Court, in complete independence, a legal solution to a case. |
Advocate General Jacobs considers that, in principle, the collective decisions to fix amounts
are prohibited by Community competition law. The Advocate General states that such a
practice effectively fixes the price for certain medicinal products, which has the object
and effect of restricting competition and is expressly identified in the EC Treaty
as being an anti-competitive practice.
However, the Advocate General notes that Community competition law is only applicable to
anti-competitive conduct engaged in by undertakings on their own initiative. If such conduct
is required by national law, competition law cannot apply. It is for the
national courts to determine whether the German law eliminates any possibility for autonomous
conduct on the part of the appellants when setting the fixed amounts. In
this respect the Advocate General suggests that the appellants were unable to avoid
fixing an amount and that the appellants were not entirely free to choose
the fixed amount because of the requirement to determine the amount on the
basis of the lowest price of the comparator group. Advocate General Jacobs therefore
suggests that the national courts should examine whether the appellants had used any
remaining discretion that they had to create an appreciably greater restriction on competition
than would have resulted from another permissible decision.
If the appellants have acted autonomously, there remains the possibility of justifying their
conduct as being a necessary and proportionate means of ensuring the provision of
a service of general economic interest. Advocate General Jacobs considers that the sickness
funds are charged with such a service. He believes that in principle the
appellants could defend their position. However, it is for the national courts to
determine whether the setting of fixed amounts is necessary in order to allow
the appellants to carry out their general interest task, that is whether the
setting of fixed amounts is indeed necessary to assure the financial stability of
the sickness funds. In doing so it would have to be shown that
the system was manifestly disproportionate for ensuring the ability of the sickness funds
to perform their tasks of general economic interest in conditions of financial stability
for such a defence to fail.
Note: After delivery of the Advocate General's Opinion, the judges of the Court
of Justice of the EC begin their deliberation on the judgment, which they
will deliver at a later date.
Available in French, English, German and Dutch. For the full text of the Opinion, please consult our internet page www.curia.eu.int at approximately 3 pm today. For further information please contact Christopher Fretwell: Tel: (00 352) 4303 3355; Fax: (00 352) 4303 2731. |